These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35182704)

  • 21. Controlling the performance of adhesive mixtures for inhalation using mixing energy.
    Thalberg K; Papathanasiou F; Fransson M; Nicholas M
    Int J Pharm; 2021 Jan; 592():120055. PubMed ID: 33176199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols.
    Zeng XM; Pandhal KH; Martin GP
    Int J Pharm; 2000 Mar; 197(1-2):41-52. PubMed ID: 10704792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H; Palakodaty S; Clark A; York P; Tzannis ST
    Int J Pharm; 2004 Aug; 281(1-2):55-66. PubMed ID: 15288343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elucidation of the effect of added fines on the performance of dry powder inhalation formulations.
    Stankovic-Brandl M; Radivojev S; Sailer P; Penz FK; Paudel A
    Int J Pharm; 2022 Dec; 629():122359. PubMed ID: 36332830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New mechanisms to explain the effects of added lactose fines on the dispersion performance of adhesive mixtures for inhalation.
    Grasmeijer F; Lexmond AJ; van den Noort M; Hagedoorn P; Hickey AJ; Frijlink HW; de Boer AH
    PLoS One; 2014; 9(1):e87825. PubMed ID: 24489969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading.
    Du P; Du J; Smyth HDC
    J Pharm Sci; 2017 Jan; 106(1):366-376. PubMed ID: 27939234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An investigation into the effect of fine lactose particles on the fluidization behaviour and aerosolization performance of carrier-based dry powder inhaler formulations.
    Kinnunen H; Hebbink G; Peters H; Shur J; Price R
    AAPS PharmSciTech; 2014 Aug; 15(4):898-909. PubMed ID: 24756910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose.
    Pinto JT; Zellnitz S; Guidi T; Roblegg E; Paudel A
    Mol Pharm; 2018 Jul; 15(7):2827-2839. PubMed ID: 29856921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of intrinsic fines in the performance change of expired lactose carriers for DPI applications.
    Bungert N; Kobler M; Scherließ R
    Eur J Pharm Biopharm; 2022 Jun; 175():7-12. PubMed ID: 35470067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of loaded carrier mass and formulation mass on aerosolization efficiency in dry powder inhaler devices.
    Ooi J; Gill C; Young PM; Traini D
    Curr Drug Deliv; 2015; 12(1):40-6. PubMed ID: 25146438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterizing the Surface Roughness Length Scales of Lactose Carrier Particles in Dry Powder Inhalers.
    Tan BMJ; Chan LW; Heng PWS
    Mol Pharm; 2018 Apr; 15(4):1635-1642. PubMed ID: 29490144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surface energy considerations in ternary powder blends for inhalation.
    Bungert N; Kobler M; Scherließ R
    Int J Pharm; 2021 Nov; 609():121189. PubMed ID: 34662648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of carrier surface fines on dry powder inhalation formulations.
    Boshhiha AM; Urbanetz NA
    Drug Dev Ind Pharm; 2009 Aug; 35(8):904-16. PubMed ID: 19466888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of mixing of fine carrier particles on dry powder inhalation property of salbutamol sulfate (SS)].
    Iida K; Leuenberger H; Fueg LM; Müller-Walz R; Okamoto H; Danjo K
    Yakugaku Zasshi; 2000 Jan; 120(1):113-9. PubMed ID: 10655787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a Rational Design Space for Optimizing Mixing Conditions for Formation of Adhesive Mixtures for Dry-Powder Inhaler Formulations.
    Sarkar S; Minatovicz B; Thalberg K; Chaudhuri B
    J Pharm Sci; 2017 Jan; 106(1):129-139. PubMed ID: 27546350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of high shear mixing on ternary dry powder inhaler formulations.
    Hertel M; Schwarz E; Kobler M; Hauptstein S; Steckel H; Scherließ R
    Int J Pharm; 2017 Dec; 534(1-2):242-250. PubMed ID: 29051120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Role of Fine Excipient Materials in Carrier-Based Dry Powder Inhalation Mixtures: Effect on Deagglomeration of Drug Particles During Mixing Revealed.
    Shalash AO; Elsayed MMA
    AAPS PharmSciTech; 2017 Nov; 18(8):2862-2870. PubMed ID: 28421352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone.
    Kaialy W; Ticehurst MD; Murphy J; Nokhodchi A
    J Pharm Sci; 2011 Jul; 100(7):2665-84. PubMed ID: 21268026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation.
    Adi H; Larson I; Chiou H; Young P; Traini D; Stewart P
    Pharm Res; 2006 Nov; 23(11):2556-65. PubMed ID: 16972185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of dry powder inhalation with lactose carrier particles surface-coated using a Wurster fluidized bed.
    Iida K; Todo H; Okamoto H; Danjo K; Leuenberger H
    Chem Pharm Bull (Tokyo); 2005 Apr; 53(4):431-4. PubMed ID: 15802846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.